MedTrace Logo

Association Between Dose Dialysis by Kt and Mortality

NCT01932853 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6129

Last updated 2016-07-13

No results posted yet for this study

Summary

The aim of this study is to assess whether patients receiving current recommendations of an adequate dialysis dose by Kt adjusted for body surface area improved survival at 24 months compared to those who do not get it, as well as assess whether patients receiving a dose greater obtain more benefit.

Conditions

Sponsors & Collaborators

  • NephroCare Spain

    lead INDUSTRY

Principal Investigators

  • Francesc Maduell, MD, Ph · Servei Nefrologia, ICNU, Hospital Clínic.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-10-31
Primary Completion
2013-12-31
Completion
2015-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01932853 on ClinicalTrials.gov